Omeros (OMER) Cash & Equivalents (2010 - 2026)
Omeros recorded quarterly Cash & Equivalents of $1.9 million in Q1 2026, down 80.27% quarter-over-quarter from $9.7 million in Q4 2025, and down 55.27% year-over-year from $4.3 million in Q1 2025.
Omeros' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 55.27% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 55.27% YoY), while the FY2025 annual figure was $9.7 million, up 184.12% from the prior year.
- Cash & Equivalents came in at $1.9 million for Q1 2026 at Omeros, down from $9.7 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $230.3 million in Q1 2024 to a low of $1.9 million in Q1 2026.
- A 5-year average of $58.8 million and a median of $11.0 million in 2022 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents soared 5960.53% in 2024 and plunged 98.15% in 2025, its largest moves.
- Omeros' Cash & Equivalents stood at $11.0 million in 2022, then sank by 35.46% to $7.1 million in 2023, then plunged by 52.15% to $3.4 million in 2024, then soared by 184.12% to $9.7 million in 2025, then slumped by 80.27% to $1.9 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $1.9 million, $9.7 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 9.66 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 28.70 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 123.20 Mn |
| Jun 30, 2024 | 158.90 Mn |
| Mar 31, 2024 | 230.30 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Sep 30, 2023 | 30.64 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 11.01 Mn |
| Sep 30, 2022 | 221.00 Mn |
| Jun 30, 2022 | 14.10 Mn |
| Mar 31, 2022 | 142.20 Mn |
| Dec 31, 2021 | 100.81 Mn |
| Sep 30, 2021 | 7.42 Mn |
| Jun 30, 2021 | 12.70 Mn |
| Mar 31, 2021 | 9.00 Mn |
| Dec 31, 2020 | 10.50 Mn |
| Sep 30, 2020 | 21.08 Mn |
| Jun 30, 2020 | 2.00 Mn |
| Mar 31, 2020 | 7.10 Mn |
| Dec 31, 2019 | 3.10 Mn |
| Sep 30, 2019 | 8.90 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Mar 31, 2019 | 4.05 Mn |
| Dec 31, 2018 | 5.90 Mn |
| Sep 30, 2018 | 2.79 Mn |
| Jun 30, 2018 | 2.88 Mn |
| Mar 31, 2018 | 1.19 Mn |
| Dec 31, 2017 | 3.39 Mn |
| Sep 30, 2017 | 1.03 Mn |
| Jun 30, 2017 | 3.39 Mn |
| Mar 31, 2017 | 1.28 Mn |
| Dec 31, 2016 | 2.22 Mn |
| Sep 30, 2016 | 10.30 Mn |
| Jun 30, 2016 | 4.59 Mn |
| Mar 31, 2016 | 978,000.00 |
| Dec 31, 2015 | 1.37 Mn |
| Sep 30, 2015 | 601,000.00 |
| Jun 30, 2015 | 2.56 Mn |
| Mar 31, 2015 | 1.44 Mn |
| Dec 31, 2014 | 354,000.00 |
| Sep 30, 2014 | 750,000.00 |
| Jun 30, 2014 | 1.53 Mn |
| Mar 31, 2014 | 567,000.00 |
| Dec 31, 2013 | 1.38 Mn |
| Sep 30, 2013 | 1.15 Mn |
| Jun 30, 2013 | 1.72 Mn |
| Mar 31, 2013 | 1.72 Mn |
| Dec 31, 2012 | 1.52 Mn |
| Sep 30, 2012 | 1.06 Mn |
| Jun 30, 2012 | 7.27 Mn |
| Mar 31, 2012 | 16.80 Mn |
| Dec 31, 2011 | 4.01 Mn |
| Sep 30, 2011 | 4.89 Mn |
| Jun 30, 2011 | 4.16 Mn |
| Mar 31, 2011 | 3.92 Mn |
| Dec 31, 2010 | 3.28 Mn |
| Sep 30, 2010 | 2.80 Mn |
| Jun 30, 2010 | 2.87 Mn |